Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Mavyret cost for 8 weeks?

See the DrugPatentWatch profile for Mavyret

The cost of Mavyret for an 8-week treatment course can vary. A 12-week prescription of Mavyret typically costs around $25,000 to $30,000 without insurance [1].

How much does an 8-week Mavyret treatment course cost without insurance?


Without insurance, an 8-week supply of Mavyret would likely be half the cost of a 12-week course, placing it in the range of $12,500 to $15,000. The actual price can fluctuate based on pharmacy and location [1].

Does insurance cover Mavyret?


Many insurance plans cover Mavyret, but coverage levels and out-of-pocket costs differ significantly. It is advisable for patients to check with their insurance provider for specific details on their Mavyret prescription benefits [1].

Are there patient assistance programs for Mavyret?


AbbVie, the manufacturer of Mavyret, offers a Mavyret Savings Card program for eligible commercially insured patients. This program can help reduce out-of-pocket costs, potentially bringing them as low as $0 for a supply of Mavyret [1]. Eligibility criteria apply to these programs.

What is Mavyret used to treat?


Mavyret is an antiviral medication used to treat chronic hepatitis C virus (HCV) infection in adults. It is indicated for all genotypes of HCV infection, including those with cirrhosis [2].

How long is a typical Mavyret treatment course?


Treatment durations for Mavyret can vary depending on the specific genotype of HCV and whether the patient has cirrhosis. Mavyret is approved for 8-week, 12-week, or 16-week treatment courses [2].

What are the potential side effects of Mavyret?


Common side effects of Mavyret include headache and fatigue. Less common side effects can also occur [2].

What is the mechanism of action for Mavyret?


Mavyret is a combination medication containing glecaprevir and pibrentasvir. Glecaprevir is an inhibitor of HCV NS3/4A protease, and pibrentasvir is an inhibitor of HCV NS5A protein. By inhibiting these proteins, Mavyret prevents the virus from replicating [2].

When does Mavyret's patent expire?


Information regarding specific patent expiration dates for Mavyret is available through resources like DrugPatentWatch.com, which tracks pharmaceutical patents [3].

Sources

1. https://www.mavyret.com/hcv-treatment-options/cost-and-support
2. https://www.mavyret.com/
3. https://drugpatentwatch.com/



Other Questions About Mavyret :

Can mavyret be used for all hep c genotypes? What are the side effects of Mavyret?